Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEARTOX: Medialipide for Uremic Toxin Clearance
NCT06595680Phase 2Not yet recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of medium-chain triglycerides + long-chain triglycerides in end stage renal disease (ESRD), sponsored by Hospices Civils de Lyon. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
medium-chain triglycerides + long-chain triglycerides
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT06595680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06595680.